Las Vegas, NV -- (SBWIRE) -- 10/30/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Synaptics, Incorporated (NASDAQ:SYNA), Lifelock Inc (NYSE:LOCK), Hanwha Solarone Co Ltd (NASDAQ:HSOL), Sarepta Therapeutics Inc (NASDAQ:SRPT)
Synaptics, Incorporated (NASDAQ:SYNA) managed to keep its gain at 3.29% on above-normal volume of 1.85M shares. The stock settled at $48.03 after floating in a range of $45.70 to $48.24. Its latest price has reached market capitalization of $1.55 billion. Its 52-week range has been $22.94 to $56.50. Synaptics Incorporated is a developer and supplier of custom-designed human interface solutions that enable people to interact with a range of mobile computing, communications, entertainment, and other electronic devices.
For How Long SYNA will fight for Profitability? Read This Trend Analysis report
Lifelock Inc (NYSE:LOCK) traded down on a volume of 1.84 million, higher than its standard daily volume. Shares have dropped-3.32% to $13.68. Over the last twelve months, the stock has gained 95.43% and faced a worst price of $6.80. LifeLock, Inc. is a provider of proactive identity theft protection services for consumers and identity risk assessment and fraud protection services for enterprises.
Has LOCK Found The Bottom And Ready To Gain Momentum? Find Out Here
Hanwha Solarone Co Ltd (NASDAQ:HSOL) settled 7.48% higher at $4.39 on below -normal volume of 1.83M shares during the last trading day. The stock has its 12-month high at $5.70 and 52-week low price was $0.77. It traded in a range of $4.03 to $4.50 during the last trading day. Hanwha SolarOne Co., Ltd. (Hanwha SolarOne) is an integrated manufacturer of silicon ingots, silicon wafers, PV cells and PV modules in China.
Why Should Investors Buy HSOL After the Recent Fall? Just Go Here and Find Out
In the last trading session, Sarepta Therapeutics Inc (NASDAQ:SRPT) was down on low volume, trading at a volume of 1.78M shares versus its average daily volume of 2.54 million shares. At $41.89, the stock has attained market capitalization of $1.40 billion. Sarepta Therapeutics Inc., formerly AVI BioPharma, Inc., biopharmaceutical company focused on the discovery and development of ribonucleic acid (RNA)-based therapeutics for the treatment of rare and infectious diseases. Its product candidates include Eteplirsen, AVI-6002, AVI-6003, and AVI-7100.
Why Should Investors Buy SRPT After the Recent Fall? Just Go Here and Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)